NYC Gazette

24 New York City biopharma companies could be negatively impacted by Inflation Reduction Act drug provision

By NYC Gazette News Service | Apr 29, 2024

A provision of the “Inflation Reduction Act” (IRA) could threaten investments in "small molecule" drug development, said a visiting professor at Rutgers University.

Espaillat thanked President Biden for giving Medicare ‘the power to negotiate lower drug prices’; some health analysts say this could lead to fewer drugs, cures

By NYC Gazette News Service | Mar 10, 2024

U.S. Rep. Adriano Espaillat (D-NY-13) thanked President Biden for his "work on the Inflation Reduction Act," which he said gave Medicare "the power to negotiate lower drug prices," but some health analysts said this could lead to fewer drugs and cures.